Wang S, Zhang Y, Zhang S, Ma S
Zhongguo Fei Ai Za Zhi. 2012; 15(9):539-44.
PMID: 22989457
PMC: 5999858.
DOI: 10.3779/j.issn.1009-3419.2012.09.06.
Brown A, Chung E, Urick M, Shield 3rd W, Sowers A, Thetford A
Radiat Oncol. 2010; 5:34.
PMID: 20459795
PMC: 2877563.
DOI: 10.1186/1748-717X-5-34.
Jensen S, Pedersen A, Vissink A, Andersen E, Brown C, Davies A
Support Care Cancer. 2010; 18(8):1061-79.
PMID: 20333412
DOI: 10.1007/s00520-010-0837-6.
Ma C, Xie J, Jiang Z, Wang G, Zuo S
Eur J Nucl Med Mol Imaging. 2010; 37(9):1778-85.
PMID: 20130857
DOI: 10.1007/s00259-009-1368-6.
Ma C, Xie J, Chen Q, Wang G, Zuo S
Cochrane Database Syst Rev. 2009; (4):CD007956.
PMID: 19821441
PMC: 6465044.
DOI: 10.1002/14651858.CD007956.pub2.
Sensitivity of salivary glands to radiation: from animal models to therapies.
Grundmann O, Mitchell G, Limesand K
J Dent Res. 2009; 88(10):894-903.
PMID: 19783796
PMC: 2882712.
DOI: 10.1177/0022034509343143.
A risk-benefit assessment of amifostine in cytoprotection.
Mabro M, Faivre S, Raymond E
Drug Saf. 1999; 21(5):367-87.
PMID: 10554052
DOI: 10.2165/00002018-199921050-00003.
The sulfhydryl containing compounds WR-2721 and glutathione as radio- and chemoprotective agents. A review, indications for use and prospects.
Hospers G, Eisenhauer E, De Vries E
Br J Cancer. 1999; 80(5-6):629-38.
PMID: 10360638
PMC: 2362304.
DOI: 10.1038/sj.bjc.6690404.
Effects of amifostine on cisplatin induced DNA adduct formation and toxicity in malignant glioma and normal tissues in rat.
Bergstrom P, Johnsson A, Bergenheim T, Henriksson R
J Neurooncol. 1999; 42(1):13-21.
PMID: 10360475
DOI: 10.1023/a:1006152103476.
Salivary gland protection by amifostine in high-dose radioiodine therapy of differentiated thyroid cancer.
Bohuslavizki K, Klutmann S, Bleckmann C, Brenner W, Lassmann S, Mester J
Strahlenther Onkol. 1999; 175(2):57-61.
PMID: 10065139
DOI: 10.1007/BF02753843.
Amifostine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential as a radioprotector and cytotoxic chemoprotector.
Spencer C, Goa K
Drugs. 1995; 50(6):1001-31.
PMID: 8612469
DOI: 10.2165/00003495-199550060-00008.
N-acetylcysteine and captopril protect DNA and cells against radiolysis by fast neutrons.
Spotheim-Maurizot M, Garnier F, Kieda C, Sabattier R, Charlier M
Radiat Environ Biophys. 1993; 32(4):337-43.
PMID: 8310128
DOI: 10.1007/BF01225921.
Radioprotection by WR-2721 in vitro at low oxygen tensions: implications for its mechanisms of action.
Durand R
Br J Cancer. 1983; 47(3):387-92.
PMID: 6299319
PMC: 2011303.
DOI: 10.1038/bjc.1983.58.
Treatment of tumours with the combination of WR-2721 and cis-dichlorodiammineplatinum (II) or cyclophosphamide.
Yuhas J, Spellman J, Jordan S, Pardini M, Afzal S, Culo F
Br J Cancer. 1980; 42(4):574-85.
PMID: 6254555
PMC: 2010452.
DOI: 10.1038/bjc.1980.282.
The effect of 2-[(aminopropyl)amino] ethanethiol (WR-1065) on radiation induced DNA double strand damage and repair in V79 cells.
Sigdestad C, Treacy S, Knapp L, Grdina D
Br J Cancer. 1987; 55(5):477-82.
PMID: 3606941
PMC: 2001724.
DOI: 10.1038/bjc.1987.97.
